Boston Scientific to sell investments for $140 m

Boston Scientific Corp., the Natick medical-device maker, said that it will sell its investments in a portfolio of companies to investment firm Saints Capital for more than $100 million.

In a separate deal, Boston Scientific says it will sell investments in a portfolio of venture funds and companies to private equity firm Paul Capital Partners for $40 million.

The company says it will record an after-tax loss of $55 million, or 4 cents per share, in the second quarter and an after-tax gain of $15 million, or 1 cent per share, during the rest of the year on the first deal.

Boston Scientific expects an after-tax loss of $6 million on the second deal.

The company says it made the sales to focus on its core business. (AP)